胎儿生长受限的遗传诊断:CMA与ES的序贯检测效能
回顾性队列纳入320例≥20周的胎儿生长受限(FGR)妊娠,评估序贯染色体微阵列(CMA)和外显子测序(ES)的诊断率。CMA在74.1%的病例中完成,FGR致病性检出率为2.1%;ES在46.6%的病例中完成,FGR致病性检出率为10.7%,非孤立型显著高于孤立型(18.5% vs. 4.8%,p=0.014)。结论支持按表型分层检测,且单基因诊断与胎盘血管病变并不互斥。
要点
- FGR总体遗传诊断率可观,ES致病性检出率(10.7%)高于CMA(2.1%)。
- 非孤立型FGR的ES致病性检出率显著高于孤立型(18.5% vs. 4.8%,p=0.014)。
- 多普勒异常不排除单基因诊断,16例ES致病病例中5例有多普勒异常。
核心结论
- FGR具有显著的遗传诊断率,支持根据表型谱进行分层检测。
- 单基因诊断与胎盘血管疾病并不互斥。
- 无论妊娠结局如何,分子病因可为遗传咨询、再发风险评估和生育计划提供信息。
研究设计与样本
- 回顾性队列研究,纳入2020-2025年单中心连续320例≥20周的FGR妊娠。
- 所有患者接受包括神经超声的详细解剖结构检查,并分为孤立型和非孤立型。
- 按器官系统、严重程度、发病孕周和多普勒状态进行特征描述,并向所有患者提供遗传咨询。
主要发现
- 孤立型FGR为199/320(62.2%),非孤立型为121/320(37.8%)。
- 早发型(<32周)为218/320(68.1%),多普勒异常为96/320(30%)。
- CMA在237/320(74.1%)中完成,异常检出率为5.5%(13/237),其中仅5/237(2.1%)被认为导致FGR表型。
- ES在149/320(46.6%)中完成,FGR致病性总检出率为10.7%(16/149),非孤立型显著高于孤立型(18.5% vs. 4.8%,p=0.014)。
- 多普勒异常并未排除单基因诊断(16例FGR致病病例中5例有多普勒异常)。
关键数值与推荐
- CMA的FGR致病性检出率为2.1%(5/237)。
- ES的FGR致病性总检出率为10.7%(16/149)。
- 非孤立型与孤立型的ES致病性检出率分别为18.5%和4.8%(p=0.014)。
临床怎么用
- 对FGR患者应提供遗传咨询,并按表型(孤立型 vs. 非孤立型)分层选择CMA和ES检测。
- 多普勒异常不应作为排除单基因检测的理由。
- 分子诊断结果可用于遗传咨询、再发风险评估及生育计划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize the overall diagnostic yield of sequential chromosomal microarray (CMA) and exome sequencing (ES) across the phenotypic spectrum of fetal growth restriction (FGR). METHODS: A retrospective cohort of 320 consecutive FGR pregnancies presenting at ≥ 20 weeks to a tertiary fetal medicine unit (2020-2025). All patients underwent a dedicated anatomical survey, including neurosonography. Cases were classified as isolated or non-isolated and characterized by organ system, severity, gestational age at onset, and Doppler status. Genetic counseling was offered to all patients. RESULTS: FGR was isolated in 199/320 (62.2%) and non-isolated in 121/320 (37.8%); 218/320 (68.1%) were early-onset (< 32 weeks) and 96/320 (30%) had abnormal Doppler. CMA was performed in 237/320 (74.1%), yielding an abnormality in 5.5% (13/237). Of these, only 5/237 (2.1%) were considered causative of the FGR phenotype. ES was performed in 149/320 (46.6%), with an overall FGR-causative yield of 10.7% (16/149), significantly higher in non-isolated versus isolated cases (18.5% vs. 4.8%; p = 0.014). Abnormal Doppler did not preclude a monogenic diagnosis (5/16 FGR-causative cases). CONCLUSIONS: FGR carries a substantial genetic yield, supporting stratified testing across the phenotypic spectrum. A monogenic diagnosis and placental vascular disease are not mutually exclusive. A molecular etiology provides information for counseling, recurrence-risk assessment, and reproductive planning, regardless of outcome.
引用
- Miremberg H, Shabat M, Stok M, et al. From Isolated to Complex: Diagnostic Yield of Chromosomal Microarray and Exome Sequencing in Fetal Growth Restriction. Prenat Diagn. 2026. PMID: 42841616. doi:10.1002/pd.70258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。